Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:2245-2263

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coromilas, J.
Right arrow Articles by Wit, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coromilas, J.
Right arrow Articles by Wit, A. L.

(Circulation. 1995;91:2245-2263.)
© 1995 American Heart Association, Inc.


Articles

Electrophysiological Effects of Flecainide on Anisotropic Conduction and Reentry in Infarcted Canine Hearts

James Coromilas, MD; Adam E. Saltman, MD, PhD; Bernd Waldecker, MD; Stephen M. Dillon, PhD; Andrew L. Wit, PhD

From the Departments of Pharmacology (A.E.S., S.M.D., A.L.W.) and Medicine (J.C.), College of Physicians and Surgeons, Columbia University, New York, NY, and the Department of Medicine (B.W.), Justus Liebig University, Giessen, Germany.

Correspondence to James Coromilas, MD, Department of Medicine, College of Physicians and Surgeons, 630 West 168th St, New York, NY 10032.

Background The class IC antiarrhythmic drug flecainide has been shown to be ineffective for the treatment of ventricular arrhythmias in some patients who have had a prior myocardial infarction and sometimes even provoke arrhythmias (proarrhythmic effect). Since some ventricular tachycardias may be caused by anisotropic reentry, we determined the effects of flecainide on this mechanism for reentry in infarcted canine hearts in order to determine possible causes for its clinical effects.

Methods and Results The effects of flecainide were determined on ventricular tachycardia induced by programmed electrical stimulation in dogs with healing myocardial infarction 4 days after coronary artery occlusion. Activation in the reentrant circuits causing tachycardia was mapped with a 196-channel computerized mapping system. We found that flecainide converted inducible unsustained ventricular tachycardia to inducible sustained ventricular tachycardia by modifying conduction in the reentrant circuit. In general, by slowing conduction, the reentrant wave front did not block after flecainide, leading to perpetuation of reentrant excitation. When sustained ventricular tachycardia could be induced before the drug, flecainide prolonged the coupling interval of premature impulses necessary to induce tachycardia by lengthening the line of block and slowing conduction around it. Flecainide also slowed the rate of the tachycardia but did not terminate it. The anisotropic reentrant circuits were modified so that the central common pathway of "figure-of-eight" circuits was narrowed and lengthened due to extension of the lines of block that bounded the pathways. Extension of the lines of block resulted from depression of conduction in the direction transverse to the long axis of the myocardial fiber bundles caused by flecainide. Flecainide also slowed conduction in the longitudinal direction in part of the circuits. The depressant effects of flecainide on both longitudinal and transverse anisotropic conduction were quantified by pacing from the center of the electrode array and it was found, contrary to predictions, that transverse conduction was depressed as much as longitudinal conduction.

Conclusions Flecainide slows conduction in both the longitudinal and transverse direction relative to the orientation of the myocardial fibers. This enables sustained reentry to occur more easily. Flecainide does not cause conduction block in crucial regions of reentrant circuits (central common pathway) and therefore does not prevent reentrant tachycardia in healing infarcts.


Key Words: ventricles • tachycardia • myocardial infarction • reentry




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
R. Veeraraghavan and S. Poelzing
Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge
Cardiovasc Res, March 1, 2008; 77(4): 749 - 756.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Fukuda, S. S. Davies, T. Nakajima, B.-H. Ong, S. Kupershmidt, J. Fessel, V. Amarnath, M. E. Anderson, P. A. Boyden, P. C. Viswanathan, et al.
Oxidative Mediated Lipid Peroxidation Recapitulates Proarrhythmic Effects on Cardiac Sodium Channels
Circ. Res., December 9, 2005; 97(12): 1262 - 1269.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Qu and J. N. Weiss
Effects of Na+ and K+ channel blockade on vulnerability to and termination of fibrillation in simulated normal cardiac tissue
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1692 - H1701.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Baba, W. Dun, and P. A. Boyden
Can PKA activators rescue Na+ channel function in epicardial border zone cells that survive in the infarcted canine heart?
Cardiovasc Res, November 1, 2004; 64(2): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Qu, H. S. Karagueuzian, A. Garfinkel, and J. N. Weiss
Effects of Na+ channel and cell coupling abnormalities on vulnerability to reentry: a simulation study
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1310 - H1321.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. I. Berul
Electrophysiological phenotyping in genetically engineered mice
Physiol Genomics, May 13, 2003; 13(3): 207 - 216.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Coromilas, C. Costeas, B. Deruyter, S. M. Dillon, N. S. Peters, and A. L. Wit
Effects of Pinacidil on Electrophysiological Properties of Epicardial Border Zone of Healing Canine Infarcts: Possible Effects of KATP Channel Activation
Circulation, May 14, 2002; 105(19): 2309 - 2317.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Nitta, M. Mitsuno, C. K. Rokkas, R. Lee, R. B. Schuessler, and J. P. Boineau
Cryoablation of ventricular tachycardia guided by return cycle mapping after entrainment
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0249 - 258.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Cabo, H. Schmitt, and A. L. Wit
New Mechanism of Antiarrhythmic Drug Action : Increasing L-Type Calcium Current Prevents Reentrant Ventricular Tachycardia in the Infarcted Canine Heart
Circulation, November 7, 2000; 102(19): 2417 - 2425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Yashima, T. Ohara, J.-M. Cao, Y.-H. Kim, M. C. Fishbein, W. J. Mandel, P.-S. Chen, and H. S. Karagueuzian
Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2124 - H2133.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Pu, J. R. Balser, and P. A. Boyden
Lidocaine Action on Na+ Currents in Ventricular Myocytes From the Epicardial Border Zone of the Infarcted Heart
Circ. Res., August 24, 1998; 83(4): 431 - 440.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. F. Kirchhof, C. L. Fabritz, and M. R. Franz
Postrepolarization Refractoriness Versus Conduction Slowing Caused by Class I Antiarrhythmic Drugs : Antiarrhythmic and Proarrhythmic Effects
Circulation, June 30, 1998; 97(25): 2567 - 2574.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs
Cardiovasc Res, March 1, 1998; 37(3): 567 - 577.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. S. Peters, J. Coromilas, M. S. Hanna, M. E. Josephson, C. Costeas, and A. L. Wit
Characteristics of the Temporal and Spatial Excitable Gap in Anisotropic Reentrant Circuits Causing Sustained Ventricular Tachycardia
Circ. Res., February 9, 1998; 82(2): 279 - 293.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Costeas, N. S. Peters, B. Waldecker, E. J. Ciaccio, A. L. Wit, and J. Coromilas
Mechanisms Causing Sustained Ventricular Tachycardia With Multiple QRS Morphologies : Results of Mapping Studies in the Infarcted Canine Heart
Circulation, November 18, 1997; 96(10): 3721 - 3731.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Cabo, B. Deruyter, J. Coromilas, and A. L. Wit
Mechanisms for Absence of Inverse Relationship Between Coupling Intervals of Premature Impulses Initiating Reentrant Ventricular Tachycardia and Intervals Between Premature and First Tachycardia Impulses
Circulation, November 4, 1997; 96(9): 3136 - 3147.
[Abstract] [Full Text]


Home page
CirculationHome page
K. T. Cragun, S. B. Johnson, and D. L. Packer
ß-Adrenergic Augmentation of Flecainide-Induced Conduction Slowing in Canine Purkinje Fibers
Circulation, October 21, 1997; 96(8): 2701 - 2708.
[Abstract] [Full Text]


Home page
CirculationHome page
N. S. Peters, J. Coromilas, N. J. Severs, and A. L. Wit
Disturbed Connexin43 Gap Junction Distribution Correlates With the Location of Reentrant Circuits in the Epicardial Border Zone of Healing Canine Infarcts That Cause Ventricular Tachycardia
Circulation, February 18, 1997; 95(4): 988 - 996.
[Abstract] [Full Text]